TrialGut2006
Fontolizumab, a humanised anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease.
D W Hommes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
77 papers cite itlatest 60 shown
this paperpooled ittrialcites it